Webinar | February.02.2021 - February.04.2021 | 9:00am - 1:30pm (Pacific Standard Time)Online webinar
Orrick is co-sponsoring TechGC SPAC & Direct Listing Forum exclusively for TechGC and its members on February 2-4, 2021.
This event will bring together General Counsels of high growth technology companies and venture funds to discuss how to approach these liquidity events strategically including evaluating which structure to use, understanding economics / dilution, and how to execute on these transactions.
Niki Fang will speak on a panel with Eleanor Lacey and Rowan Reynolds from Asana on February 4th at 10:55am on "Buttoning Up for a Direct Listing: Considerations, Unique Characteristics, and Reflections."
In addition to that, Matthew Gemello, Hari Raman, Stephen Thau and Albert Vanderlaan are each leading a breakout session on February 2nd at 9:00am PT discussing about the SPAC process checklist.
CLE Credits Available: Y
Niki Fang is a partner in Orrick’s Capital Markets practice.
Niki concentrates her corporate practice on representing issuers and underwriters in public offerings and capital markets transactions. Niki also regularly counsels public and late-stage private companies on securities law compliance, disclosure matters, SEC reporting obligations, corporate governance and stock exchange listing obligations. In addition, Niki’s practice includes venture capital financings and advising start-up companies on general corporate matters. She represents a wide range of technology and life sciences companies, from privately held start-ups to publicly traded corporations.
Prior to joining Orrick, Niki was at Fenwick & West LLP and Davis Polk & Wardwell LLP.
Matthew Gemello, a corporate partner in the Silicon Valley office, leads our global Corporate Business unit.
A seasoned deal lawyer, Matthew guides global technology companies and their financial sponsors through transformational domestic and cross-border transactions. These deals range from private company buyouts and public takeovers in the United States and around the world, to complex, multi-jurisdictional spinoffs and business carveouts.
Matthew has been recognized as a leading lawyer by numerous publications, including Legal 500 and he was selected by the San Francisco and Los Angeles Daily Journal as one of the top 10 Innovative Corporate Lawyers in California.
Hari Raman, a partner working across our Bay Area offices in our Corporate group, is a member of our Global Mergers & Acquisitions and Private Equity practices.
Hari represents private equity firms and public, private, emerging and late-stage technology companies in a variety of domestic and international transactions. His experience spans the range of M&A activity, including cross-border deals, SPAC transactions, majority/minority investments, restructurings and general corporate matters. He works closely with serial acquirers implementing their buy-side M&A strategies, and with venture-backed companies, founders and investors in M&A exits and other liquidity transactions.
Hari has extensive experience leading companies in core technology markets through all aspects of the M&A process. He understands the unique issues, deal terms and trends at play in technology M&A, allowing him to optimize for efficiency, transaction execution and results for his clients.
Hari has also previously worked in Asia and the Middle East on complex, cross-border M&A, and leverages that experience in leading M&A transactions across the globe, including China, India, Israel and the United Kingdom.
Prior to joining Orrick, Hari was an associate at Gibson, Dunn & Crutcher LLP. He is qualified to practice in both California and New York.
Stephen Thau is co-chair of the Life Sciences Group at Orrick and is a partner in the firm's Technology Companies Group. He is a strategic advisor to life sciences and technology companies, guiding them through various milestones of their life cycle.
Stephen’s practice focuses on the representation of life science, medical device, health IT, and other technology companies in transactional matters, including public and private financings, licensing, collaborations and strategic alliances, and mergers and acquisitions. He also represents venture capital firms in public and private financing transactions.
Stephen is recognized as a Leading Life Sciences Lawyer by LMG Life Sciences in their 2021/2022 rankings and short-listed as Venture Capital Attorney of the Year. He has served as a member of the Board of Tech Council of Maryland, the leading technology and life science association in that state, and of BayBio, Northern California’s leading life sciences association. Stephen is a frequent speaker on venture capital financings and served on the faculty at the 2005 and 2007 Emerging Entrepreneurs workshops at Stanford University.Prior to joining Orrick, Stephen was a partner at Morrison & Foerster, Venture Law Group and Heller Ehrman. He began his legal practice as a litigator, focusing on securities and intellectual property. ;He also served as a law clerk to the Hon. Vaughn R. Walker in the United States District Court in the Northern District of California. Stephen graduated Order of the Coif from Stanford Law School, where he was managing editor of the Stanford Law Review, and graduated magna cum laude from Harvard College in Biology.
Albert Vanderlaan is a partner in Orrick’s Capital Markets Group. He works with public and private companies, SPACs, SPAC sponsors, venture capital firms and investment banks focused on the life sciences and high-growth technology sectors.
Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including IPOs, follow-on public offerings, private and public company securities law compliance matters, public company disclosure obligations, de-SPAC transactions, SPAC IPOs, venture financings and mergers and acquisitions. He also regularly advises public and private companies and their boards of directors on corporate governance issues.
Albert's clients include public and private companies in technology, automotive, Internet related industries, real estate, finance and the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies). He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.
Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”